Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00339586
Status:
UNKNOWN
Last Update Posted:
2006-06-21
First Post:
2006-06-19
Brief Title:
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Sponsor:
AZ-VUB
Organization:
AZ-VUB
Organization Data
Organization:
AZ-VUB
Class:
OTHER
Study ID:
FIELT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AZ-VUB
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |